Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Claudia Sorbi
Observed names:
C. Sorbi,
Sorbi, C.,
Sorbi, Claudia
Institution:
University of Modena and Reggio Emilia
Observed institutions:
Università di Camerino,
University of Modena and Reggio Emilia,
AREA Science Park,
University of Catania,
Recordati (Italy)
ORCID:
0000-0001-6916-4933
Observed ORCID:
0000-0001-6916-4933
OpenAlex ID:
A5077228484
1,3‐Dioxolane‐Based Ligands as Rigid Analogues of Naftopidil: Structure–Affinity/Activity Relationships at α1 and 5‐HT1A Receptors
2009
·
Claudia Sorbi
, Silvia Franchini
, et al.
·
ChemMedChem
·
39
1,3-Dioxolane-Based Ligands as a Novel Class of α1-Adrenoceptor Antagonists
2003
·
Livio Brasili
, Claudia Sorbi
, et al.
·
Journal of Medicinal Chemistry
·
38
A homology modelling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (TAAR5) antagonists
2015
·
Elena Cichero
, Stefano Espinoza
, et al.
·
MedChemComm
·
35
Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists
2016
·
Silvia Franchini
, Leda Ivanova Manasieva
, et al.
·
European Journal of Medicinal Chemistry
·
34
1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: Structure–affinity/activity relationship at α1-adrenoceptor subtypes and at 5-HT1A receptors
2010
·
Silvia Franchini
, Adolfo Prandi
, et al.
·
European Journal of Medicinal Chemistry
·
28
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents
2023
·
Pasquale Linciano
, Claudia Sorbi
, et al.
·
European Journal of Medicinal Chemistry
·
27
PDF
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity
2019
·
Silvia Franchini
, Claudia Sorbi
, et al.
·
European Journal of Medicinal Chemistry
·
27
PDF
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer
2023
·
Davide Moi
, Davide Bonanni
, et al.
·
European Journal of Medicinal Chemistry
·
26
PDF
Discovery of a new series of 5-HT1A receptor agonists
2010
·
Silvia Franchini
, Adolfo Prandi
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
26
Synthesis and Structure−Activity Relationships of 1-Aralkyl-4-Benzylpiperidine and 1-Aralkyl-4-Benzylpiperazine Derivatives as Potent σ Ligands
2004
·
Luca Costantino
, Francesca Gandolfi
, et al.
·
Journal of Medicinal Chemistry
·
25
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs)
2020
·
Pasquale Linciano
, Rosaria Benedetti
, et al.
·
Bioorganic Chemistry
·
24
PDF
Synthesis of 6-O-methotrexylhyaluronan as a drug delivery system
2008
·
Claudia Sorbi
, Massimo Bergamin
, et al.
·
Carbohydrate Research
·
24
Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status
2023
·
Luca Pinzi
, Nicolò Bisi
, et al.
·
Molecules
·
22
PDF
Identification of a Potent and Selective 5-HT1A Receptor Agonist with In Vitro and In Vivo Antinociceptive Activity
2020
·
Pasquale Linciano
, Claudia Sorbi
, et al.
·
ACS Chemical Neuroscience
·
17
PDF
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents
2020
·
Silvia Franchini
, Pasquale Linciano
, et al.
·
ACS Medicinal Chemistry Letters
·
15
PDF
Structure–affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α<alpha>1 and 5-HT1A receptors
2014
·
Silvia Franchini
, Umberto M. Battisti
, et al.
·
European Journal of Medicinal Chemistry
·
15
(2,2‐Diphenyl‐[1,3]oxathiolan‐5‐ylmethyl)‐(3‐phenyl‐propyl)‐amine: a Potent and Selective 5‐HT1A Receptor Agonist
2008
·
Silvia Franchini
, Annalisa Tait
, et al.
·
ChemMedChem
·
15
Synthesis and Biological Evaluation of 1,3-dioxolane-based 5-HT1AReceptor Agonists for CNS Disorders and Neuropathic Pain
2018
·
Silvia Franchini
, Leda Ivanova Bencheva
, et al.
·
Future Medicinal Chemistry
·
14
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor
2014
·
Umberto M. Battisti
, Sandra Corrado
, et al.
·
MedChemComm
·
13
Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer
2025
·
Andrea Citarella
, Silvia Belluti
, et al.
·
Journal of Medicinal Chemistry
·
12
PDF
Synthesis and Structure–Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands
2014
·
Sandra Corrado
, Umberto M. Battisti
, et al.
·
Chemical Biology & Drug Design
·
12
Structure–activity relationship at α-adrenergic receptors within a series of imidazoline analogues of cirazoline
2000
·
Maria Pigini
, Wilma Quaglia
, et al.
·
Bioorganic & Medicinal Chemistry
·
12
Exhaustive CoMFA and CoMSIA analyses around different chemical entities: a ligand-based study exploring the affinity and selectivity profiles of 5-HT1A ligands
2017
·
Sara Guariento
, Silvia Franchini
, et al.
·
Journal of Enzyme Inhibition and Medicinal Chemistry
·
11
PDF
Structure–Activity Relationships within a Series of σ1 and σ2 Receptor Ligands: Identification of a σ2 Receptor Agonist (BS148) with Selective Toxicity against Metastatic Melanoma
2017
·
Silvia Franchini
, Claudia Sorbi
, et al.
·
ChemMedChem
·
10
PDF
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group
2021
·
Pasquale Linciano
, Luca Pinzi
, et al.
·
Journal of Enzyme Inhibition and Medicinal Chemistry
·
9
PDF
Show more works
View as search
Works count:
73
Citation count:
570
H-index:
15
I10-index:
24
Year
Topic
Type